MET and cancer: (i) In the mutated, amplified or otherwise genetically altered form, c-Met generates and maintains transformed phenotype, and drives clonal evolution; (ii) in the wild-type form, c-Met contributes to maintain - in the cancer stem cell - the phenotype ‘inherent’ in the stem/progenitor cell of origin [4].